Arachnoiditis means the thin middle lining around your spinal cord—the arachnoid membrane—gets inflamed. This lining normally protects the nerves and lets spinal fluid flow smoothly. When it becomes inflamed, the nerves can get irritated, swollen, and even stick together with scar tissue. That irritation can cause burning back or leg pain, tingling or numbness, weakness, and sometimes bladder, bowel, or sexual problems. In many people, symptoms can be long-lasting because the inflammation may lead to scarring (adhesions). NINDS+2GARD Information Center+2
Arachnoiditis means long-lasting inflammation of the arachnoid mater, one of the thin coverings (meninges) around your brain and spinal cord. In the spine, this inflammation can thicken the delicate membranes, create scar tissue, make nerve roots stick together (“adhesive arachnoiditis”), block the normal flow of spinal fluid, and cause chronic neuropathic pain, numbness, weakness, and bladder or bowel troubles. It is uncommon, hard to cure, and treatment focuses on easing symptoms and improving daily life. MRI often shows nerve-root clumping, arachnoid cysts, or other supportive signs; there is no single lab test that “proves” it. Surgery usually does not help and can sometimes worsen scarring, so care is typically non-surgical and multidisciplinary.
Other names
People and articles may use different names for the same problem. Common terms include:
-
Arachnoiditis (general term)
-
Spinal arachnoiditis
-
Adhesive arachnoiditis (when scar tissue makes nerves “stick” together)
-
Chronic adhesive arachnoiditis (long-lasting scarring form)
-
Arachnoiditis ossificans (a rare form where bone-like tissue forms inside the arachnoid)
These names describe the same basic idea—ongoing inflammation in the arachnoid layer—but they hint at how severe or advanced the changes are. Radiopaedia+2American Journal of Roentgenology+2
Types
It helps to think of types by how the nerves look on imaging and how much scarring has formed:
1) Non-adhesive (early or milder inflammation).
There is irritation and swelling of the arachnoid and nerve roots, but little or no scar tissue yet. Symptoms can still be painful, but imaging may show only subtle changes.
2) Adhesive arachnoiditis (AA).
This means nerves and the arachnoid have formed adhesions (scar bands). On MRI, doctors often see nerve roots that are “clumped” together or pulled to the outer wall of the sac. In some people, the center of the sac looks “empty” because the roots are stuck around the edges—called the “empty thecal sac sign.” These patterns are classic clues for arachnoiditis. Radiopaedia
3) Advanced chronic adhesive arachnoiditis.
With time, inflammation and scarring can become more widespread. MRI can show thicker, matted nerve roots. Sometimes swelling of the cord above or below the scarred area occurs and can even mimic other diseases, which is why careful imaging review is important. American Journal of Roentgenology
4) Arachnoiditis ossificans.
This very rare form includes calcium or bone-like deposits forming inside the arachnoid layer. MRI and especially CT/myelography may show these hard deposits. It is linked in older cases to past use of oil-based myelogram dyes (no longer used), which could trigger long-term inflammation and later calcification. PubMed+2ScienceDirect+2
Causes
Arachnoiditis has many triggers. Most fit into four buckets: mechanical (injury/compression), chemical (irritants), infections, and autoimmune/inflammatory conditions. Here are 20 well-recognized causes and how they make trouble:
-
Spinal surgery (any level).
Surgery can irritate the meninges, cause bleeding, or lead to scarring. The healing response can inflame the arachnoid and cause nerve roots to adhere over time. NCBI -
Spinal procedures with needle entry (e.g., epidural anesthesia, lumbar puncture).
Any puncture can introduce minor bleeding or chemicals, which in rare cases provoke arachnoid inflammation. NCBI -
Intrathecal medications (past practices).
Certain agents given into spinal fluid (now uncommon) could irritate the arachnoid and trigger scarring in susceptible people. NCBI -
Old oil-based myelography contrast (e.g., iofendylate).
These legacy dyes (no longer used) were linked to chronic arachnoiditis and even later calcification (ossificans) decades after exposure. PubMed -
Chemical contamination (e.g., antiseptics getting into the CSF).
Accidental chemical irritation can inflame the arachnoid and nerve roots. NCBI -
Subarachnoid hemorrhage (SAH) or bleeding around the cord.
Blood breakdown products irritate the arachnoid, promoting inflammation and scarring. NCBI -
Direct spinal trauma.
A fracture or severe back injury can inflame the meninges and set off arachnoiditis. NCBI -
Chronic nerve compression (e.g., severe spinal stenosis or large disc herniation).
Ongoing mechanical irritation and poor CSF flow can drive local inflammation of the arachnoid over time. GARD Information Center -
Bacterial meningitis (general).
Bacteria inflame all meninges; the arachnoid layer can scar as the infection resolves. MedlinePlus -
Tuberculous meningitis.
TB can cause thick, sticky (“exudative”) meningitis that scars the arachnoid and can trap nerve roots. MedlinePlus -
Fungal meningitis (e.g., coccidioidomycosis).
Fungal infections inflame the meninges; CSF often shows high white cells and protein. Chronic inflammation can lead to arachnoiditis. PubMed Central -
Viral meningitis (e.g., varicella-zoster).
Some viral infections irritate spinal nerve roots and the arachnoid, sometimes leaving lasting pain. MedlinePlus -
Neurosyphilis (Treponema pallidum).
Inflammation of the meninges in late syphilis can involve the arachnoid and spinal roots. MedlinePlus -
Lyme neuroborreliosis.
Borrelia infection can inflame nerve roots (radiculitis) and meninges, causing arachnoid irritation. MedlinePlus -
Sarcoidosis (neurosarcoid).
Granulomas can form along the meninges, including the arachnoid, leading to scarring and nerve dysfunction. NCBI -
Connective tissue disease (e.g., mixed connective tissue disease).
Autoimmune inflammation can involve the meninges and lead to adhesive arachnoiditis in rare cases. BMJ Case Reports -
Postoperative infection (meningitis or arachnoiditis).
An infection after surgery can directly inflame the arachnoid layer. NCBI -
Chronic inflammatory CSF disorders of unknown cause (idiopathic).
Sometimes no clear trigger is found—yet the arachnoid is inflamed and scarred. NCBI -
Spinal tumors or prior tumor treatments (radiation).
Tumors or radiation may irritate meninges and disturb CSF flow, encouraging inflammation and adhesions. NCBI -
Prior intradural infections or cysts that disturb CSF flow (e.g., arachnoid cyst rupture/irritation).
Disturbed fluid dynamics and local inflammation can involve the arachnoid, especially near cysts or prior lesions. Cleveland Clinic
Symptoms
Symptoms vary widely. Some people have steady pain; others have flares. Location often matches where the inflammation and scarring are:
-
Burning low-back pain that may spread to one or both legs. This is the most common complaint. NINDS
-
Electric-shock or stinging sensations (paresthesias) in the legs or feet. GARD Information Center
-
Tingling or numbness in a “stocking-like” pattern. GARD Information Center
-
Leg weakness or heaviness, sometimes worse after standing or walking. NCBI
-
Worsening pain with movement (standing, sitting long, or certain positions). NINDS
-
Muscle cramps or spasms in the calves or thighs due to irritated nerves. NINDS
-
Gait problems—limp, short steps, fear of falling—when pain or weakness flares. NCBI
-
Back stiffness and reduced range of motion from guarding and chronic inflammation. NINDS
-
Bladder problems—urgency, frequency, leakage, or trouble starting urination. GARD Information Center
-
Bowel dysfunction—constipation or incontinence in more severe cases. GARD Information Center
-
Sexual dysfunction—reduced sensation or erectile problems. GARD Information Center
-
Saddle anesthesia—numbness between the legs (serious sign needing urgent care). NCBI
-
Sleep disturbance from constant pain or night cramps. NINDS
-
Mood changes (low mood, anxiety) that commonly accompany chronic pain. NINDS
-
Flare-and-fade pattern—symptoms can change day to day; the course is often unpredictable. sfn.org
Diagnostic tests
Doctors combine your story, a careful exam, and targeted tests. No single test “proves” arachnoiditis in every case, but patterns across several tests build the diagnosis.
A) Physical examination
-
Full neurological exam.
Your clinician checks strength, sensation (light touch, pin, vibration), and reflexes in the legs; compares sides; and looks for nerve-root patterns of loss. A clear pattern of radiculopathy (specific root irritation) supports the diagnosis and guides the imaging level. PubMed Central -
Gait and balance assessment.
Observation while walking, turning, and standing on heels/toes helps reveal weakness, foot drop, or pain-avoidant gait. These findings, while not specific, show functional effect of nerve irritation. NCBI -
Spinal range-of-motion and posture check.
Forward bending, extension, and side-bending may provoke nerve pain or stiffness and hint at the levels most involved. This helps target MRI sequences. NCBI -
Bladder and bowel screening in the history plus exam.
Asking about leakage, retention, and constipation, and checking perineal sensation and anal tone when needed, screens for cauda equina involvement. NCBI -
Tenderness mapping and paraspinal muscle exam.
Palpation can localize painful segments and reveal protective muscle spasm, which often accompanies chronic nerve irritation. NCBI
B) Manual tests
-
Straight-Leg Raise (SLR) test.
With you lying down, the leg is lifted with the knee straight. Reproduction of typical shooting pain down the leg suggests root irritation. SLR is sensitive but not very specific—it’s better for ruling out than ruling in. NCBI+2Physiopedia+2 -
Slump test.
Sitting with a rounded back and extended leg can tension the sciatic nerve. Pain eased by releasing the neck/leg tension supports a nerve-tension component. Like SLR, it is more sensitive than specific. PubMed Central -
Femoral nerve stretch test.
With the hip extended and knee flexed (often lying on the stomach), pain in the front of the thigh suggests upper lumbar nerve-root irritation. It complements SLR when higher levels are suspected. PubMed Central -
Repeated-movement testing (extension/flexion bias).
Simple repeated motions can provoke or centralize symptoms, helping localize the painful level and guide imaging and therapy plans. NCBI -
Functional tests (sit-to-stand, heel/toe walk, single-leg stance).
These quick screens demonstrate endurance of nerve-driven muscles (like calf and toe extensors). Asymmetry or rapid fatigue supports radiculopathy. NCBI
C) Laboratory & pathological tests
-
Basic blood tests for inflammation (CBC, ESR, CRP).
These look for signs of infection or systemic inflammation that could be irritating the arachnoid. They are non-specific but helpful for the big picture. NCBI -
CSF analysis (lumbar puncture) when infection or inflammatory disease is suspected.
Cell counts, protein, glucose, cultures, and PCR help detect meningitis (bacterial, TB, fungal, viral) and guide targeted treatment. Findings vary by cause; for example, fungal meningitis often shows elevated cells and protein. PubMed Central -
Serologic tests for infections.
Blood and CSF antibody/culture/PCR panels (e.g., syphilis tests, TB studies, Lyme, coccidioides) are chosen based on risk factors and geography. PubMed Central -
Autoimmune screening when indicated.
Tests such as ANA (autoimmune screen) or ACE (sarcoidosis) may be ordered if the history suggests inflammatory causes. Results are interpreted with imaging and clinical signs. NCBI -
Microbiology/cytology from surgery (rarely).
If surgery is performed for another reason and tissue is available, pathology can confirm chronic inflammation, fibrosis, or rare ossific changes. American Journal of Roentgenology
D) Electrodiagnostic tests
-
Nerve conduction studies (NCS).
Measure how fast and how strongly nerves carry signals. They help distinguish root problems from peripheral nerve disease. In arachnoiditis, patterns often match affected roots. NCBI -
Electromyography (EMG).
A tiny needle records muscle electrical activity. EMG can show which roots are chronically irritated or denervated, complementing MRI findings. NCBI -
Somatosensory evoked potentials (SSEPs) (selected cases).
These measure signal travel through the spinal cord pathways. Abnormalities can indicate disrupted conduction from scarring or inflammation. Used when diagnosis is complex. NCBI
E) Imaging tests
-
MRI of the spine (with/without contrast).
This is the main test. Common MRI clues are thickened or “clumped” nerve roots, roots stuck to the sac wall (empty thecal sac sign), or enhancement around roots after contrast. MRI also helps rule out other causes like tumors or severe stenosis. Radiopaedia+1 -
CT myelography.
A contrast dye is injected into the spinal fluid and CT images are taken. It can show fine details of nerve-root outlines and adhesions, and may better reveal calcified or ossified plaques. It’s especially useful when MRI is unclear or when ossificans is suspected. (Modern water-based dyes are used today; older oil-based agents—no longer used—were linked to arachnoiditis.) American Journal of Roentgenology+1 -
MRI sequences tailored to advanced disease.
Radiologists may use specific T2-weighted and post-contrast sequences to highlight subtle root thickening, syrinx above/below, or cord edema in advanced chronic adhesive arachnoiditis. American Journal of Roentgenology -
CT (non-myelogram) for ossificans.
Thin-cut CT is excellent for detecting calcium/bone within the arachnoid and for mapping the extent before surgery is considered. AJNR -
Dynamic or region-focused MRI at symptomatic levels.
When your symptoms point to a specific level (for example, L4-L5), targeted high-resolution imaging improves detection of subtle root clumping. Radsource -
Whole-axis screening MRI in complex cases.
When imaging and symptoms don’t match, doctors may scan more of the spine to look for another level of scarring or a syrinx (fluid cavity) that complicates the picture. American Journal of Roentgenology -
Myelography (Modern indications).
Occasionally chosen when MRI cannot be performed or is nondiagnostic, modern myelography still helps outline root sleeves and adhesions. (Again, current agents differ from the old oil-based dyes linked to complications.) MedlinePlus -
Urodynamic testing (adjunct).
If bladder symptoms are prominent, measuring bladder pressures and sphincter coordination documents neurogenic dysfunction from root involvement, guiding care. NCBI
Non-pharmacological treatments (therapies & “how they help”)
Important: There’s no cure, but combining several low-risk strategies often improves pain, function, and mood. These are adapted from broad chronic-pain guidelines (CDC 2022; WHO 2023 for chronic back pain) and tailored to arachnoiditis. PubMed Central+3CDC+3CDC+3
-
Education & reassurance – Understand that pain is real, often neuropathic, and pacing plus multi-modal care can help. Knowing why surgery is rarely helpful reduces fear and supports self-management. NINDS+1
-
Graded activity (pacing) – Break tasks into small steps, with planned rests, to avoid pain flares while building endurance. Recommended across pain guidelines. CDC
-
Individualized exercise – Gentle walking, core-stability, and mobility work maintain strength, protect joints, and reduce pain sensitivity. Start low, go slow. World Health Organization
-
Aquatic therapy – Water buoyancy reduces load on irritated tissues, enabling movement with less pain. World Health Organization
-
Physiotherapy coaching – Targeted programs for posture, neural mobility, and safe movement patterns; therapists also guide pacing and flare plans. World Health Organization
-
Cognitive behavioral therapy (CBT) – Helps reframe unhelpful thoughts, lower pain-related anxiety, and improve coping and sleep. World Health Organization
-
Mindfulness/relaxation – Simple breathing, body-scan, or meditation to calm the nervous system and reduce pain amplification. CDC
-
Sleep hygiene – Regular schedule, screen limits, and a cool, dark room reduce central sensitization and improve daytime function. CDC
-
Heat/ice as needed – Short sessions can soothe muscle guarding and flare pain; combine with movement. CDC
-
Ergonomics & load-management – Neutral spine positions, sit-stand alternation, supportive seating, and avoiding prolonged static postures lower mechanical stress. World Health Organization
-
Weight management (if needed) – Even modest loss reduces axial load and may help pain and mobility. World Health Organization
-
Smoking cessation – Smoking worsens spinal healing and pain outcomes; quitting supports overall recovery. CDC
-
Acupuncture (trial) – May help some people with chronic back pain; try a time-limited course and continue only if helpful. World Health Organization
-
Spinal manipulative therapy or massage (select patients) – Consider short, monitored trials for nonspecific components of pain; avoid if neurologic deficits or instability. World Health Organization
-
TENS (home unit) – Noninvasive electrical stimulation that can reduce perceived pain intensity in some patients. CDC
-
Pelvic-floor therapy – For urinary urgency/frequency or bowel symptoms related to neurogenic dysfunction. NCBI
-
Assistive devices – Cushions for sitting intolerance; canes or walkers if gait is unsteady—safety first. NCBI
-
Return-to-meaningful-activities plan – Restoring valued hobbies/social roles improves mood and lowers pain disability. CDC
-
Multidisciplinary care – Coordinated input from pain medicine, physiatry, PT, and psychology improves outcomes. NCBI
-
Avoid unnecessary invasive spine procedures – Reduces added scarring and risk of worsening adhesive disease. NCBI
Drug treatments
Care is individualized. Many of these are off-label for arachnoiditis but commonly used for neuropathic pain. Start with the lowest effective dose, check interactions, and reassess regularly. PubMed Central+2Cochrane+2
-
Acetaminophen – For background nociceptive pain; schedule or as needed within safe daily limits. Protects stomach but monitor liver. Guideline-consistent as a non-opioid option. CDC
-
NSAIDs (e.g., naproxen, ibuprofen) – Help with inflammatory flares and neighboring musculoskeletal pain; use the lowest dose, shortest time; watch GI, kidney, and CV risks. World Health Organization
-
Gabapentin – First-line for many neuropathic pains; typical total daily dose 1800–3600 mg in divided doses if tolerated; dizziness/sedation are common. Evidence strongest for diabetic neuropathy/PHN, but often tried across neuropathic conditions. Cochrane
-
Pregabalin – Similar mechanism; often 150–600 mg/day in divided doses; may work when gabapentin does not; monitor for edema, weight gain, and sedation. ScienceDirect
-
Duloxetine (SNRI) – Benefits neuropathic pain and comorbid anxiety/depression; typical 60–120 mg/day; watch nausea, BP changes. ScienceDirect
-
Amitriptyline/Nortriptyline (TCAs) – Low bedtime doses (10–75 mg) can reduce nerve pain and help sleep; anticholinergic side effects and cardiac cautions in older adults. ScienceDirect
-
Topical lidocaine 5% patches – Useful for focal neuropathic pain areas; low systemic risk. CDC
-
Capsaicin 8% patch (clinic-applied) – Can reduce local neuropathic pain after a single application lasting weeks; transient burning is common. ScienceDirect
-
Tramadol – Consider short-term and carefully (dependency and side-effects); can help intermittent severe flares when other options fail. Follow CDC safety guidance. CDC
-
Opioids – Not first-line for chronic neuropathic pain; if used, follow CDC 2022 guidance: lowest dose, clear goals, time-limited trial, risk mitigation. CDC+1
-
Short steroid taper (acute/subacute inflammatory flare) – May reduce acute meningeal inflammation; not a long-term solution; risks include hyperglycemia and infection. Evidence is mixed; use selectively. PubMed Central
-
Low-Dose Naltrexone (LDN) – 1.5–4.5 mg nightly is studied for centralized/neuropathic pain; proposed microglial modulation; generally well-tolerated; still emerging evidence. Oxford Academic+2PubMed Central+2
-
Palmitoylethanolamide (PEA) (pharmacologic-grade) – An endogenous fatty-acid amide that may calm neuroinflammation (PPAR-α); used as add-on in chronic neuropathic pain; safety profile is favorable; evidence growing but not definitive. PubMed Central+2PubMed Central+2
-
Bladder antimuscarinics or β3-agonists – For urgency/frequency due to neurogenic bladder; chosen by urology. NCBI
-
Baclofen or tizanidine – For troublesome muscle spasm; monitor sedation and weakness; avoid chronic high doses. CDC
-
SNRIs other than duloxetine (e.g., venlafaxine) – Alternative in those who can’t take duloxetine; watch BP. ScienceDirect
-
Topical NSAIDs – For localized mechanical pain components with lower systemic risk. CDC
-
Short-course nerve blocks (diagnostic/therapeutic) – Part of interventional pain pathways; effects are usually temporary; avoid repeated procedures without a clear plan. CDC
-
Epidural adhesiolysis (percutaneous lysis of adhesions) – Interventional option in selected cases with supportive RCT evidence for specific pain syndromes; benefits must be weighed against procedure risks and study limitations. PubMed Central+1
-
Spinal cord stimulation (SCS) – For refractory neuropathic pain; modern systems show improved outcomes in trials vs medical therapy in selected chronic pain populations, though evidence is debated and patient selection is critical. JAMA Network+1
Dietary / molecular supplements
Supplements do not replace core therapies. Use them only as add-ons after checking safety and interactions.
-
PEA (palmitoylethanolamide) – 300–600 mg 2×/day (varies by product); proposed PPAR-α activation dampens neuroinflammation; emerging evidence for chronic pain; generally well-tolerated. PubMed Central+1
-
Omega-3 (EPA/DHA) – ~1–2 g/day combined EPA+DHA from fish oil; anti-inflammatory and membrane-stabilizing effects; limited neuropathic pain data but biologically plausible and safe for many. ScienceDirect+1
-
Vitamin D – Supplement only if deficient, per blood test; vitamin D alone does not consistently reduce chronic pain, but deficiency should be corrected for general health. Nature+1
-
Alpha-lipoic acid (ALA) – 600 mg/day has evidence in diabetic neuropathy; antioxidant and mitochondrial effects; monitor GI upset. ScienceDirect
-
Magnesium – 200–400 mg elemental/day (as glycinate or citrate) may aid muscle relaxation and sleep; avoid in kidney disease. Evidence for neuropathic pain is limited. CDC
-
Curcumin (with piperine or formulated for absorption) – Anti-inflammatory signaling (NF-κB); human neuropathic data are limited; consider short trial if no interactions. CDC
-
Vitamin B12 – Replete only if low; deficiency can worsen neuropathy; dosing depends on level (oral or IM). CDC
-
CoQ10 – Antioxidant/mitochondrial support; evidence in neuropathic pain is preliminary. CDC
-
Probiotics/fiber for bowel regularity – Helpful if medications cause constipation; indirect benefit for comfort and activity. CDC
-
Melatonin (sleep) – 1–5 mg at night can improve sleep, which may lower pain centralization; check for morning grogginess. CDC
Immunity booster / regenerative / stem-cell” drugs
There are no proven, approved stem-cell or “regenerative” drug treatments for arachnoiditis. Claims online are often unregulated. Some experimental ideas seek to modulate neuroinflammation or immunity, but they should only be pursued in clinical trials. Here’s a reality-check summary:
-
Low-dose naltrexone (LDN) – Immune-modulating (microglial) hypothesis; studied across chronic pain; consider as an adjunct under medical supervision. Oxford Academic
-
PEA – Endogenous lipid with neuroimmune-modulating actions (PPAR-α); adjunct only. PubMed Central
-
Short, carefully selected corticosteroid courses – For acute/subacute inflammatory flares only; not regenerative; weigh risks. PubMed Central
-
IVIG or disease-specific immunotherapies – Only if a defined autoimmune/infectious trigger exists and specialists advise it; not routine for arachnoiditis. NCBI
-
Autologous stem-cell injections / intrathecal biologics – Not recommended outside trials due to safety and lack of efficacy data. NCBI
-
Radiation/anti-fibrotic concepts – Experimental and not standard of care; risks may outweigh benefits. PubMed Central
Procedures & surgeries (when and why)
-
Spinal Cord Stimulation (SCS) – Implantable device that reduces pain signaling; considered for severe, refractory neuropathic pain after comprehensive conservative care; selection and expectations are crucial. Evidence from recent RCT syntheses shows benefit vs medical therapy in certain chronic pain populations, but not all patients respond. JAMA Network
-
Percutaneous epidural adhesiolysis – Catheter-based lysis of scar tissue in selected patients; RCTs suggest benefit for some epidural adhesion pain syndromes, though methods vary and not all centers agree. PubMed Central+1
-
Targeted decompression/lysis of intradural adhesions – Reserved for rare, well-defined focal pathology with matching symptoms; outcomes are inconsistent and recurrence can occur. PubMed Central
-
CSF diversion (shunt) or syrinx management – Considered if arachnoid scarring leads to syringomyelia or CSF flow obstruction with progressive deficits. NCBI
-
Intrathecal drug delivery pumps – For highly refractory pain when other options fail; requires careful risk–benefit discussion and ongoing monitoring. CDC
Multiple reputable sources note that surgery is often not beneficial for diffuse adhesive arachnoiditis and may aggravate scarring; decisions must be individualized at experienced centers. NINDS+1
Prevention tips
-
Keep vaccinations and infection prevention up to date to reduce meningitis risks. NCBI
-
Avoid unnecessary invasive spinal procedures; use imaging-guided, sterile techniques when indicated. NCBI
-
If you need spinal surgery, choose centers with strong infection-control and meticulous tissue handling. NCBI
-
Manage autoimmune conditions with your specialist to lower inflammatory flares. NCBI
-
Use the pacing + graded activity approach to avoid severe flare-ups. CDC
-
Maintain core strength and flexibility with a gentle, regular exercise plan. World Health Organization
-
Stop smoking; it impairs healing. CDC
-
Keep body weight in a healthy range to reduce mechanical load. World Health Organization
-
Optimize sleep habits to reduce central sensitization. CDC
-
Build a multidisciplinary team early (pain, physiatry, PT, psychology). NCBI
When to see a doctor urgently
Seek urgent care for new or worsening leg weakness, numbness in the saddle area, loss of bladder or bowel control, fever with severe back pain, or rapidly escalating pain after an invasive spinal procedure. These can signal complications that need immediate attention. NCBI
What to eat (and what to limit)
-
Emphasize whole foods: vegetables, fruits, legumes, whole grains, nuts, olive oil, and fish (omega-3s). Adequate protein supports muscle maintenance for rehab. ScienceDirect
-
Stay hydrated and include fiber to prevent constipation (common with some pain meds). CDC
-
If vitamin D deficient, replete per labs and clinician advice; routine high-dose vitamin D for pain without deficiency is not helpful. Nature
-
Limit alcohol (sleep/pain quality), excess sugars and ultra-processed foods (inflammation/weight), and smoking (healing). CDC
Frequently asked questions
-
Is arachnoiditis curable? No single cure exists; symptom control and function improvement are realistic goals. NCBI
-
Can it get worse? Course varies—some remain stable; others fluctuate or slowly progress. Monitor changes and treat flares early. NCBI
-
Will MRI always show it? MRI is helpful but not perfect; imaging and symptoms can mismatch. NCBI
-
Is surgery the answer? Usually no; it may worsen scarring. Some carefully selected cases benefit from SCS or targeted procedures. NINDS+1
-
Are steroids safe? Short courses may help acute inflammation; they’re not a long-term fix and carry risks. PubMed Central
-
Do opioids help? They’re not first-line; if used, follow CDC 2022 safety recommendations with clear goals and exit plans. CDC
-
What medicines help nerve pain? Gabapentin, pregabalin, SNRIs (like duloxetine), and TCAs are common first/second-line options. PubMed Central+1
-
What about LDN? Early evidence suggests it may help some chronic neuropathic pain; discuss a monitored trial with your doctor. Oxford Academic
-
Does PEA work? Meta-analyses suggest potential benefit with good tolerability; quality varies by product. PubMed Central
-
Are supplements mandatory? No. Use only as adjuncts; test and correct deficiencies (e.g., vitamin D, B12) rather than “mega-dosing.” Nature
-
Can exercise make it worse? The wrong dose can flare pain; graded exercise with pacing helps most people over time. World Health Organization
-
Is arachnoiditis life-threatening? Not usually, but it can be disabling and affect quality of life. Support for mental health is important. NCBI
-
Can bladder symptoms improve? Yes—behavioral strategies, pelvic-floor therapy, and medications can help. NCBI
-
What if I can’t sit long? Use cushions, posture changes, sit-stand breaks, and pacing; ask PT for a tailored plan. World Health Organization
-
Where to get trustworthy information? National institutes, academic pain programs, and evidence syntheses—not anecdotal social media posts. NINDS+1
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: September 21, 2025.